AC Immune (ACIU) Total Non-Current Liabilities (2015 - 2025)

AC Immune (ACIU) has 11 years of Total Non-Current Liabilities data on file, last reported at $18.4 million in Q4 2025.

• Quarterly Total Non-Current Liabilities fell 9.67% year-over-year to $18.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.4 million (down 9.67% YoY) and the FY2025 annual result came in at $17.7 million, down 12.92% from the prior year.
• Total Non-Current Liabilities rose to $18.4 million in Q4 2025 per ACIU's latest filing, from $13.6 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $10.9 billion in Q2 2021 and bottomed at $2.0 million in Q3 2022.
• The 5-year median for Total Non-Current Liabilities is $15.1 million (2024), against an average of $2.6 billion.
• The widest annual swing landed in 2022, when Total Non-Current Liabilities slumped 99.98%; it then surged 170677.33% in 2023.
• Tracing ACIU's Total Non-Current Liabilities over 5 years: stood at $10.2 billion in 2021, then sank by 99.94% to $5.7 million in 2022, then surged by 170677.33% to $9.7 billion in 2023, then tumbled by 99.79% to $20.3 million in 2024, then fell by 9.67% to $18.4 million in 2025.
• Per Business Quant, the three latest ACIU Total Non-Current Liabilities figures stand at $18.4 million (Q4 2025), $13.6 million (Q3 2025), and $19.9 million (Q2 2025).

Peer Comparison